Fosamprenavir Calcium Patent Expiration
Fosamprenavir Calcium is Used for managing and treating HIV infection. It was first introduced by Viiv Healthcare Co
Fosamprenavir Calcium Patents
Given below is the list of patents protecting Fosamprenavir Calcium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lexiva | US6436989 | Prodrugs of aspartyl protease inhibitors |
Dec 24, 2017
(Expired) | Viiv Hlthcare |
| Lexiva |
US6436989 (Pediatric) | Prodrugs of aspartyl protease inhibitors |
Jun 24, 2018
(Expired) | Viiv Hlthcare |
| Lexiva | US6514953 | Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
Jul 15, 2019
(Expired) | Viiv Hlthcare |
| Lexiva |
US6514953 (Pediatric) | Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
Jan 15, 2020
(Expired) | Viiv Hlthcare |
Try Our Curated Drug Screens
Fosamprenavir Calcium Generics
Several generic applications have been filed for Fosamprenavir Calcium. The first generic version for Fosamprenavir Calcium was by Mylan Pharmaceuticals Inc and was approved on Apr 15, 2016. And the latest generic version is by Sun Pharmaceutical Industries Ltd and was approved on Nov 20, 2019.
Given below is the list of companies who have filed for Fosamprenavir Calcium generic.
1. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Fosamprenavir Calcium. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 700MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Apr 15, 2016 |
2. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Fosamprenavir Calcium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 700MG BASE | tablet | Prescription | ORAL | AB | Nov 20, 2019 |